In a 12-week single-arm pilot trial, twenty adults with early-stage Huntington's disease adopted a self-selected 6-to-8-hour daily eating window and showed a 0.50-point improvement on the composite Unified Huntington's Disease Rating Scale, against an expected annual decline of roughly one point. Plasma neurofilament light, a marker of axonal injury that typically rises as the disease advances, fell by a mean of 12.6%. Weight was largely preserved and adherence was high, establishing feasibility in a population vulnerable to unintended weight loss.
Key Points
- Composite Huntington's rating improved 0.50 points over 12 weeks
- Plasma neurofilament light fell 12.6% on average, reversing expected trend
- No control group; motor gains lost significance after multiple-testing correction
Longevity Analysis
Meal timing alters metabolic and repair signaling independently of calorie restriction, and here that shift registered in a fluid biomarker of nerve-fiber integrity rather than in symptom scores alone. Huntington's is genetically determined in onset mechanism but variable in timing and trajectory, which places modifiable inputs — when energy arrives, how efficiently mitochondria handle it, whether cellular clearance pathways get an unfed interval to operate — within reach of intervention. Adherence was the operative variable: a self-selected window sustained for twelve weeks, with weight monitored closely, is what made the biological signal measurable at all.
Original published by LifeSpan.io, by Arkadi Mazin.